Hairmax CEO Ryan Zackon Makes Commitment to Advancing Diversity and Inclusion in the Workplace
09 août 2023 08h59 HE
|
Hairmax
BOCA RATON, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneering leader in transformative hair growth announced today that its CEO, Ryan Zackon, is joining other chief executive officers...
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
03 août 2023 17h32 HE
|
Structure Therapeutics Inc.
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...
Hairmax Offers Hair Growth & Wellness Guide During Hair Loss Awareness Month
03 août 2023 08h59 HE
|
Hairmax
BOCA RATON, Fla., Aug. 03, 2023 (GLOBE NEWSWIRE) -- August is recognized as National Hair Loss Awareness Month, a time to bring attention to an issue that affects a significant number of people at...
ParaZero Technologies Ltd. Announces Closing of $7.8 Million Initial Public Offering
31 juil. 2023 09h38 HE
|
ParaZero Technologies Ltd.
KIRYAT ONO, ISRAEL, July 31, 2023 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (“ParaZero” or the “Company”) today announced the closing of its initial public offering of 1,950,000 ordinary shares...
Janover Inc. Announces Closing of $5.65 Million Initial Public Offering
27 juil. 2023 16h05 HE
|
Janover Inc.
Boca Raton, FL, July 27, 2023 (GLOBE NEWSWIRE) -- Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), a B2B fintech marketplace connecting commercial property borrowers and lenders with a...
Medigus‘ Drones Safety Company, ParaZero (PRZO), to Commence Trading on Nasdaq Today
27 juil. 2023 09h00 HE
|
Medigus Ltd
ParaZero Announces Initial Public Offering (IPO) Pricing of $7.8 million Tel Aviv, Israel, July 27, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in...
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
21 juil. 2023 02h15 HE
|
Turnstone Biologics Corp.
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...
60 Degrees Pharmaceuticals Announces Closing of Initial Public Offering
14 juil. 2023 12h39 HE
|
Sixty Degrees Pharmaceuticals
WASHINGTON, July 14, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), specialists in developing and marketing medicines for infectious...
60 Degrees Pharmaceuticals Announces Pricing of Initial Public Offering
12 juil. 2023 12h29 HE
|
Sixty Degrees Pharmaceuticals
WASHINGTON, July 12, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP; SXTPW) ("60P" or the "Company"), specialists in developing and marketing medicines for infectious...
AI Therapeutics Announces Appointment of Biotechnology Industry Leader David Scheer as Chairman of the Board of Directors
12 juil. 2023 11h45 HE
|
AI Therapeutics, Inc.
GUILFORD, Conn., July 12, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the appointment...